Watch for Mix-Ups With the New COPD Three-Drug Inhaler Combo Trelegy Ellipta

Trelegy Ellipta (TREL-eh-gee) will be the first "three-in-one" inhaler for COPD.

It contains the long-acting muscarinic antagonist (LAMA) umeclidinium...the long-acting beta-agonist (LABA) vilanterol...and the inhaled corticosteroid (ICS) fluticasone furoate.

Trelegy is a dry-powder inhaler given as a single puff once daily.

Get unlimited access through an Enterprise license

Hospital Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Not sold to individuals